Becton Dickinson Total Liabilities 2012-2026 | BDX
Becton Dickinson total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Becton Dickinson total liabilities for the quarter ending March 31, 2026 were $29.559B, a 0.34% increase year-over-year.
- Becton Dickinson total liabilities for 2025 were $29.935B, a 4.65% decline from 2024.
- Becton Dickinson total liabilities for 2024 were $31.396B, a 16.35% increase from 2023.
- Becton Dickinson total liabilities for 2023 were $26.984B, a 2.42% decline from 2022.
|
Becton Dickinson Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $29,935 |
| 2024 | $31,396 |
| 2023 | $26,984 |
| 2022 | $27,652 |
| 2021 | $30,189 |
| 2020 | $30,247 |
| 2019 | $30,684 |
| 2018 | $32,910 |
| 2017 | $24,786 |
| 2016 | $17,953 |
| 2015 | $19,314 |
| 2014 | $7,394 |
| 2013 | $7,106 |
| 2012 | $7,225 |
| 2011 | $5,602 |
|
Becton Dickinson Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-12-31 | $29,559 |
| 2025-09-30 | $29,935 |
| 2025-06-30 | $29,430 |
| 2025-03-31 | $29,226 |
| 2024-12-31 | $29,460 |
| 2024-09-30 | $31,396 |
| 2024-06-30 | $29,714 |
| 2024-03-31 | $28,510 |
| 2023-12-31 | $26,942 |
| 2023-09-30 | $26,984 |
| 2023-06-30 | $27,080 |
| 2023-03-31 | $28,705 |
| 2022-12-31 | $27,657 |
| 2022-09-30 | $27,652 |
| 2022-06-30 | $27,706 |
| 2022-03-31 | $30,261 |
| 2021-12-31 | $29,203 |
| 2021-09-30 | $30,189 |
| 2021-06-30 | $30,199 |
| 2021-03-31 | $30,094 |
| 2020-12-31 | $30,085 |
| 2020-09-30 | $30,247 |
| 2020-06-30 | $29,937 |
| 2020-03-31 | $32,565 |
| 2019-12-31 | $30,750 |
| 2019-09-30 | $30,684 |
| 2019-06-30 | $30,736 |
| 2019-03-31 | $31,289 |
| 2018-12-31 | $31,528 |
| 2018-09-30 | $32,910 |
| 2018-06-30 | $32,620 |
| 2018-03-31 | $33,421 |
| 2017-12-31 | $34,116 |
| 2017-09-30 | $24,786 |
| 2017-06-30 | $24,579 |
| 2017-03-31 | $16,158 |
| 2016-12-31 | $16,735 |
| 2016-09-30 | $17,953 |
| 2016-06-30 | $17,983 |
| 2016-03-31 | $18,570 |
| 2015-12-31 | $18,823 |
| 2015-09-30 | $19,314 |
| 2015-06-30 | $19,826 |
| 2015-03-31 | $21,134 |
| 2014-12-31 | $13,435 |
| 2014-09-30 | $7,394 |
| 2014-06-30 | $6,996 |
| 2014-03-31 | $6,935 |
| 2013-12-31 | $6,957 |
| 2013-09-30 | $7,106 |
| 2013-06-30 | $6,871 |
| 2013-03-31 | $7,041 |
| 2012-12-31 | $7,160 |
| 2012-09-30 | $7,225 |
| 2012-06-30 | $6,790 |
| 2012-03-31 | $6,719 |
| 2011-12-31 | $6,686 |
| 2011-09-30 | $5,602 |
| 2011-06-30 | $5,322 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |